OncoDaily Biotech

[OncoDaily Biotech @OncoDailyBio]

What Does It Take for Cancer Survivors to Truly Thrive? - Laura Makaroff and Mohit Manrao

@lauramakaroff @mohitmanrao

https://t.co/bYrWuhjcqK

[OncoDaily Biotech @OncoDailyBio]

Innovation in Oncology Where Significant Unmet Need Remains – Jazz Pharmaceuticals

@JazzPharma @ChumiKhurana

https://t.co/U3RJPcNqR4

[OncoDaily Biotech @OncoDailyBio]

Belén Garijo on Co-Creating Patient Metrics With Global Advocacy Organizations

@sanofi

https://t.co/NLsOYFBjWu

[OncoDaily Biotech @OncoDailyBio]

Global Pharma is Buying China’s Oncology Pipeline - Nelson Liu

@AstraZeneca

https://t.co/0CTQea7S74

[OncoDaily @oncodaily]

On June 17, 2026, the leaders of the G7—Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States—alongside Brazil, Egypt, India, Kenya, and the Republic of Korea, issued a joint call to accelerate global efforts against cancer.

The declaration highlights commitments to strengthen international cooperation in cancer research, prevention, early detection, innovation, data sharing, and access to quality cancer care, with particular focus on pediatric, adolescent, and young adult cancers, as well as cancers with poor prognosis.

https://t.co/ebsQ2XKsAr

@POTUS @realDonaldTrump @EmmanuelMacron @bundeskanzler @GiorgiaMeloni @Keir_Starmer @MarkJCarney @takaichi_sanae @WilliamsRuto @LulaOficial @narendramodi @AlsisiOfficial @G7

[OncoDaily Biotech @OncoDailyBio]

Walid Kamoun on How AI Is Reshaping Oncology R&D

@Servier

https://t.co/6YRYw9ZTWs

[OncoDaily Biotech @OncoDailyBio]

Applications are still open for the EURACAN Summer School on Research Methodology and Ethics in Rare Cancers

@ERN_EURACAN

https://t.co/NWaIVdphs8

[OncoDaily Biotech @OncoDailyBio]

Jazz Pharmaceuticals - Leveraging Biomarker Strategies to Target HER2-Expressing Cancers

@JazzPharma

https://t.co/uU39m74oHl

[OncoDaily Biotech @OncoDailyBio]

Servier - Join the Fun Run and Walk in Munich

@Servier

https://t.co/S4Ej4IBUtb

[OncoDaily Biotech @OncoDailyBio]

Robert Iannone Discusses Innovation in HER2 Cancer Care – Jazz Pharmaceuticals

@JazzPharma

https://t.co/k5P7lnRw32

[OncoDaily Biotech @OncoDailyBio]

The ADC land grab just found a new frontier.

@JNJNews is paying $1B for #FireflyBio's DAC platform — same antibody precision, but the payload degrades proteins instead of poisoning cells.

https://t.co/5VW6NoMVP0

[OncoDaily Biotech @OncoDailyBio]

Advancing Hematology Research at EHA 2026 - Bristol Myers Squibb

@bmsnews

https://t.co/dtM0LIItTT

[OncoDaily Biotech @OncoDailyBio]

Ahmed Magdy Rabea Joins Expert Discussion on Gastric and Gastroesophageal Cancers in Libya

@arabea81 @AstraZeneca

https://t.co/ptGAGuXEcX

[OncoDaily Biotech @OncoDailyBio]

. @Roche is betting big on BTK degradation🧬

Its up-to-$2.3B @Nurix_Tx deal brings bexobrutideg, an oral BTK degrader, closer to Phase III CLL testing after early data showed an 80.9% ORR in heavily pre-treated CLL.

Read more: https://t.co/9BjK16pM3s

[Gevorg Tamamyan @GevTamamyan]

Don’t take yourself too seriously: Michael Bailey

The best advice one can receive! Very motivating and inspirational talk with the CEO of AVEO Oncology.
Thank you very much, Michael! It was really a great pleasure.

https://t.co/DRDN6h5qYl

@AVEOOncology @oncodaily @OncoDailyGU @OncoDailyBio

[OncoDaily Biotech @OncoDailyBio]

HER2 is an Oncogenic Driver Across a Range of Malignancies - Robert Iannone

@JazzPharma

https://t.co/YoJmrCgpW9

[OncoDaily Biotech @OncoDailyBio]

New Perspectives and New Connections at ASCO 2026 – Summit Therapeutics

@SMMT_TX

https://t.co/FV7P0clR7L

[OncoDaily Biotech @OncoDailyBio]

What Still Brings Me Back to ASCO After 25 Years - Sunil Verma

@cancermd

https://t.co/VKDdOQLoCi

[OncoDaily Biotech @OncoDailyBio]

🩸One blood draw. 10 cancers.

@US_FDA just granted Breakthrough Device Designation to SPOT-MAS 10 from @GeneSolutions
that detects cancer signals across 10 types, including 5 with no standard screening today. 🧬

https://t.co/aFiFY0HaVI

[OncoDaily Biotech @OncoDailyBio]

Bayer Head Invites Colleagues To Connect At Booth 13059 During ASCO26 - Tara Frenkl

@ASCO @Bayer

https://t.co/cAT0d2iX1K